Poster Abstract Session:
73. Vaccines
Thursday, October 27, 2016: 12:30 PM-2:00 PM
Room: Poster Hall

Learning Objectives:

.

Tracks: Pediatric ID, Adult ID

Presentations:
709
Do Low Vitamin D Levels Explain Poorer Influenza Vaccine Immunogenicity among HIV-Infected and HIV-Uninfected Adults?
Nancy Crum-Cianflone, MD, MPH ; Seunghyun Won, PhD ; Rachel Lee, MD ; Tahaniyat Lalani, MD ; Anuradha Ganesan, MD, MPH ; Timothy Burgess, MD ; Brian Agan, MD
Posters
  • Vit D poster IDSA FINAL.pdf (481.8 kB)
  • 710
    Impact of Frailty on Influenza Vaccine Effectiveness and Clinical Outcomes: Experience from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) Network 2011/12 Season
    Melissa K Andrew, MD, PhD ; Sarah Macdonald, BSc ; Lingyun Ye, PhD ; Ardith Ambrose, RN ; Guy Boivin, MD, MSc ; Francisco Diaz-Mitoma, MD, PhD ; William Bowie, MD, FRCPC, FIDSA ; Ayman Chit, MBiotech, PhD ; Gael Dos Santos, PhD ; May Elsherif, MD ; Karen Green, MSc ; Todd Hatchette, MD ; Francois Haguinet, PhD ; Scott a. Halperin, MD ; Barbara Ibarguchi, MSc ; Jennie Johnstone, MD ; Kevin Katz, MD, CM, MSc, FRCPC ; Philippe Lagace-Wiens, MD ; Joanne M. Langley, MD, FRCPC, FSHEA ; Jason Leblanc, PhD ; Bruce Light, MD ; Mark Loeb, MD, MSc ; Donna Mackinnon-Cameron, MMath ; Anne E. Mccarthy, MD ; Janet E. Mcelhaney, MD ; Allison Mcgeer, MD, MSc ; Andre Poirier, MD, MSc ; Jeff Powis, MD, MSc, FRCPC ; David Richardson, MD ; Makeda Semret, MD ; Vivek Shinde, MD, MPH ; Stephanie Smith, MD, MSc ; Daniel Smyth, MD, FRCPC ; Grant Stiver, MD ; Geoffrey Taylor, MD, FSHEA ; Sylvie Trottier, MD ; Louis Valiquette, MD, MSc ; Duncan Webster, MD ; Shelly a Mcneil, MD, FRCPC, FIDSA
    711
    Comparison of Influenza Vaccine Effectiveness Estimates Using Data from the Influenza Incidence Surveillance Project and the US Influenza Vaccine Effectiveness Network, 2011–12 through 2014–15.
    Jessie Chung, MPH ; Ashley Fowlkes, MPH ; Mark G. Thompson, PhD ; Andrea Steffens, MPH ; Sarah Spencer, PhD ; Swathi Thaker, PhD ; Alicia M. Fry, MD, MPH ; Brendan Flannery, PhD
    712
    Bordetella Pertussis (Bp): impact of pregnancy Tdap vaccination strategy in a pediatric hospital. Times series study. 2003-2016
    Angela Gentile, MD ; Ana Clara Martinez, MD ; Maria Florencia Lucion, MD ; Viviana Romanin, MD ; Maria De Los Angeles Marques, Biochemistry ; Alicia Mistchenko, MD ; Maria Del Valle Juarez, MD
    714
    Zoster Vaccine Live: A Review of Nearly 10 Years of Postmarketing Experience
    English Willis, MD, FAAP ; Meredith Woodward, MSN, RN ; Zoran Popmihajlov, MD ; Elizabeth Brown, MS ; Patricia Saddier, MD, PhD ; Neal Halsey, MD, FIDSA ; Anne Gershon, MD, FIDSA, FPIDS
    715
    VZV Cell-Mediated Immunity 3 Years After The Administration Of Zoster Vaccine To Septuagenarians Immunized 10 Years Previously
    Adriana Weinberg, MD ; Myron Levin, MD, FIDSA ; Kenneth Schmader, MD ; Michael Johnson, MD ; Yupanqui Caldas, MD ; Jennifer Canniff, MD ; Alice Cho, BS ; Barbara Mccarson, MD ; Jason Martin, MD ; Zoran Popmihajlov, MD
    716
    Effect of influenza vaccine on Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in older population
    Maryam Keshtkar-Jahromi, MD, MPH ; Min Ouyang, MD ; Marzieh Keshtkarjahromi, MD ; Samah Almed, MS ; Huifen Li, PhD ; Jeremy Walston, MD ; Rebeca Rios, PhD ; Sean Leng, MD, PhD
    Posters
  • IDSA Influenza Poster.pdf (349.1 kB)
  • CME Credits: No CME credit is offered for this session.

    ACPE Credits:

    ACPE Number:


    Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.